AmorChem II Ventures Inc. is a venture capital fund located in Montreal focused on creating life science companies from promissing projects originating primarily from Quebec-based universities and research centres. Its principal limited partners are Investissement-Québec, FIER Partenaires, Fonds de solidarité FTQ and Merck & Co. AmorChem’s innovative business model involves investing in research-stage projects to enable them to reach a stage where they can attract other financial partners. AmorChem has built a 24-project portfolio across innovative technologies and covering a large breadth of indications.

In addition, in order to enable projects requiring small molecules as tools or drug leads, AmorChem founded NuChem Therapeutics Inc., a medicinal chemistry contract-research company.


Dre Inès Holzbaur
General Partner

Phone (514) 849-7454
Fax (514) 849-5191


1 Westmount Square
Suite 800, Montréal, Qc, Canada

Investment sought

  • Early Stage
  • Later Stage
  • Seed Round
  • Investment sectors

  • Healthcare & Life Sciences
  • Investment status

  • Actively seeking new investments
  • Reducing investment activity
  • Investment limits (in millions)

    Min : 1.2

    Max : 5.2

    Deal limits (in millions)

    Min : 0.5

    Max : 9